An experimental drug for treatment of Ebola has been provided by a Nigerian in diaspora and will arrive the country today, the minister for health, Onyebuchi Chukwu, has said.
The drug, called “Nanosilver”, can now be used following the approval by the World Health Organization (WHO) that experimental treatments are ethical in the case of the Ebola pandemic.
The Nigerian government authorized the use of experimental drugs on Wednesday. The US sent ZMapp, another experimental drug, to Liberia on Wednesday, while Canada has decided to donate 1,000 vaccines to the affected countries.
According to Chukwu, the experimental drug is a donation from a Nigerian scientist who was concerned about threat of Ebola in his home country.